SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 15-12B - Securities registration termination [Section 12(b)]:
SEC Accession No. 0001193125-14-427858
Filing Date
2014-11-28
Accepted
2014-11-28 09:56:05
Documents
1
Effectiveness Date
2014-11-28

Document Format Files

Seq Description Document Type Size
1 15-12B d827016d1512b.htm 15-12B 9894
  Complete submission text file 0001193125-14-427858.txt   10918
Mailing Address 200 SOUTH WACKER DRIVE SUITE 2550 CHICAGO IL 60606
Business Address 200 SOUTH WACKER DRIVE SUITE 2550 CHICAGO IL 60606 312-219-7000
Durata Therapeutics, Inc. (Filer) CIK: 0001544116 (see all company filings)

IRS No.: 871247903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 15-12B | Act: 34 | File No.: 001-35599 | Film No.: 141255111
SIC: 2834 Pharmaceutical Preparations